When biotech startups emerge from stealth, executives typically talk about new molecules in the pipeline and novel approaches they take to treating a disease. The founders of Generate Biomedicines want to discuss none of those things, yet they contend their technology will upend the way protein drugs are discovered and developed.
Cambridge, MA-based Generate has been plugging away at its research within the labs of venture capital firm Flagship Pioneering for the past three years. On Thursday, the startup pulled back the curtain enough to give a glimpse of its technology, its potential applications, and the plans to use that platform… Read more »
UNDERWRITERS AND PARTNERS
